TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00306267

A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“Study stopped as it would not address important survival concerns raised in other recently conducted clinical studies.”

The sponsor’s own words in the registry.

Life of this trial

200620072008Started2006-03Registered2006-03-21Stopped2007-05

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Sponsor type
Industry
Conditions
Anemia; Cancer; Epoetin Alfa
Interventions
epoetin alfa
Participants
61

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.